Changes in Seroprevalence and Wellness Over Time in Healthcare Workers (CONSERVE-HCW)

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04595175

Acronym

CONSERVE-HCW

Enrollment

2000

Registered

2020-10-20

Start date

2020-06-10

Completion date

2021-12-30

Last updated

2020-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 Infection

Keywords

Serology, Wellness, SARS-CoV-2 IgG, Seroprevalence, Healthcare Workers

Brief summary

The Investigators propose a multi-center, observational, longitudinal, cohort study of the serology and wellness of HCWs over a year of the COVID-19 pandemic.

Detailed description

All consenting participants will undergo survey assessment and diagnostic testing with the Abbott Architect SARS-CoV-2 IgG assay (IgG) every three months for a one year period. Clinical outcomes and related data capture will be performed at this same interval.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

1. Age greater than or equal to 18 years; and 2. Be an active member of the CommonSpirit Health workforce or medical staff during the COVID-19 pandemic and at the time of enrollment; and 3. Have access to the Internet; and 4. The ability to provide informed consent.

Exclusion criteria

1. Subjects that lack the ability for longitudinal follow-up; and/or 2. Subjects that do not meet the above inclusion criteria. -

Design outcomes

Primary

Measure	Time frame	Description
Baseline IgG Assay Information	Baseline	Seroprevalence of anti-SARS-CoV-2 IgG antibodies in HCWs
Change in IgG Assay Information	From Baseline to 3 months, 6 months, 9 months, & 12 months	The change in the seroprevalence of anti-SARS-CoV-2 IgG antibodies in HCWs over one year.
Compare seroprevalence of anti-SARS-CoV-2 IgG antibodies between groups	From Baseline to 3 months, 6 months, 9 months, & 12 months	Compare seroprevalence of anti-SARS-CoV-2 IgG antibodies in 'front-line' workers and non-'front-line' HCWs
Impact of COVID-19 Pandemic on Perceived Wellness and Job Satisfaction	Baseline to 12 months	Over the 12 months of the study, evaluate the impact of the COVID-19 pandemic on HCW wellness using the Perceived Wellness Survey. Job satisfaction will be measured using a locally developed questionnaire.

Countries

United States

Contacts

Primary ContactAndrea B. Garcia, MBA

andrea.garcia2@dignityhealth.org602-406-9769

Backup ContactJennine Zumbuhl, RN, MSHA

jennine.zumbuhl@dignityhealth.org480-728-3674

Outcome results